全文获取类型
收费全文 | 3259篇 |
免费 | 328篇 |
国内免费 | 5篇 |
出版年
2021年 | 37篇 |
2020年 | 22篇 |
2019年 | 36篇 |
2018年 | 50篇 |
2017年 | 31篇 |
2016年 | 66篇 |
2015年 | 103篇 |
2014年 | 117篇 |
2013年 | 181篇 |
2012年 | 179篇 |
2011年 | 207篇 |
2010年 | 127篇 |
2009年 | 112篇 |
2008年 | 163篇 |
2007年 | 140篇 |
2006年 | 145篇 |
2005年 | 136篇 |
2004年 | 146篇 |
2003年 | 143篇 |
2002年 | 160篇 |
2001年 | 75篇 |
2000年 | 59篇 |
1999年 | 46篇 |
1998年 | 38篇 |
1997年 | 41篇 |
1996年 | 27篇 |
1995年 | 32篇 |
1994年 | 25篇 |
1993年 | 33篇 |
1992年 | 38篇 |
1991年 | 44篇 |
1990年 | 29篇 |
1989年 | 43篇 |
1988年 | 54篇 |
1987年 | 44篇 |
1986年 | 40篇 |
1985年 | 43篇 |
1984年 | 32篇 |
1983年 | 32篇 |
1982年 | 44篇 |
1981年 | 38篇 |
1980年 | 35篇 |
1979年 | 24篇 |
1978年 | 33篇 |
1977年 | 19篇 |
1976年 | 26篇 |
1975年 | 22篇 |
1974年 | 27篇 |
1973年 | 24篇 |
1972年 | 26篇 |
排序方式: 共有3592条查询结果,搜索用时 15 毫秒
1.
Jennifer Dumont Don Euwart Baisong Mei Scott Estes Rashmi Kshirsagar 《Critical reviews in biotechnology》2016,36(6):1110-1122
Biotherapeutic proteins represent a mainstay of treatment for a multitude of conditions, for example, autoimmune disorders, hematologic disorders, hormonal dysregulation, cancers, infectious diseases and genetic disorders. The technologies behind their production have changed substantially since biotherapeutic proteins were first approved in the 1980s. Although most biotherapeutic proteins developed to date have been produced using the mammalian Chinese hamster ovary and murine myeloma (NS0, Sp2/0) cell lines, there has been a recent shift toward the use of human cell lines. One of the most important advantages of using human cell lines for protein production is the greater likelihood that the resulting recombinant protein will bear post-translational modifications (PTMs) that are consistent with those seen on endogenous human proteins. Although other mammalian cell lines can produce PTMs similar to human cells, they also produce non-human PTMs, such as galactose-α1,3-galactose and N-glycolylneuraminic acid, which are potentially immunogenic. In addition, human cell lines are grown easily in a serum-free suspension culture, reproduce rapidly and have efficient protein production. A possible disadvantage of using human cell lines is the potential for human-specific viral contamination, although this risk can be mitigated with multiple viral inactivation or clearance steps. In addition, while human cell lines are currently widely used for biopharmaceutical research, vaccine production and production of some licensed protein therapeutics, there is a relative paucity of clinical experience with human cell lines because they have only recently begun to be used for the manufacture of proteins (compared with other types of cell lines). With additional research investment, human cell lines may be further optimized for routine commercial production of a broader range of biotherapeutic proteins. 相似文献
2.
Roberta Bianchi Eliane Fischer Don Yuen Ellen Ernst Alexandra M. Ochsenbein Lu Chen Vivianne I. Otto Michael Detmar 《The Journal of biological chemistry》2014,289(30):21016-21027
The lymphatic system plays an important role in cancer metastasis and inhibition of lymphangiogenesis could be valuable in fighting cancer dissemination. Podoplanin (Pdpn) is a small, transmembrane glycoprotein expressed on the surface of lymphatic endothelial cells (LEC). During mouse development, binding of Pdpn to the C-type lectin-like receptor 2 (CLEC-2) on platelets is critical for the separation of the lymphatic and blood vascular systems. Competitive inhibition of Pdpn functions with a soluble form of the protein, Pdpn-Fc, leads to reduced lymphangiogenesis in vitro and in vivo. However, the transgenic overexpression of human Pdpn-Fc in mouse skin causes disseminated intravascular coagulation due to platelet activation via CLEC-2. In the present study, we produced and characterized a mutant form of mouse Pdpn-Fc, in which threonine 34, which is considered essential for CLEC-2 binding, was mutated to alanine (PdpnT34A-Fc). Indeed, PdpnT34A-Fc displayed a 30-fold reduced binding affinity for CLEC-2 compared with Pdpn-Fc. This also translated into fewer side effects due to platelet activation in vivo. Mice showed less prolonged bleeding time and fewer embolized vessels in the liver, when PdpnT34A-Fc was injected intravenously. However, PdpnT34A-Fc was still as active as wild-type Pdpn-Fc in inhibiting lymphangiogenesis in vitro and also inhibited lymphangiogenesis in vivo. These data suggest that the function of Pdpn in lymphangiogenesis does not depend on threonine 34 in the CLEC-2 binding domain and that PdpnT34A-Fc might be an improved inhibitor of lymphangiogenesis with fewer toxic side effects. 相似文献
3.
4.
5.
6.
7.
Sense and nonsense in bacterial taxonomy 总被引:1,自引:0,他引:1
S T Cowan 《Journal of general microbiology》1971,67(1):1-8
8.
9.
Published gene frequency data, checked for consistency of allele definitions across laboratories and for comparability of
geographically identical samples, were pooled into a data set containing frequencies at nine loci for each of 20 populations
that encompassed 10 macaque species. Genetic distances were calculated by the methods of Kidd and Cavalli-Sforza (1974). These
distances were used to construct phylogenetic trees and to evaluate the relationships between divergence times and effective
population sizes. Inter-and intraspecific genetic distances and the groupings defined by phenetic tree analyses support Fooden’s
(1976) classification of the genus Macacainto four species groups. A paleozoogeographical model of Asia including the known times of major sea-level changes allows
us to explain Macacainto four species groups. A paleozoogeographical model of Asia including the known times of major sea-level changes allows
us to explain qualitatively the inferred evolutionary relationships among macaque species. Many assumptions are required in
order to estimate the variables necessary in the quantitative prediction of genetic differences for a comparison between any
two populations. Examination of those assumptions demonstrates the need for more accurate genetic as well as paleozoogeographic
information.
An erratum to this article is available at . 相似文献
10.
The efficacies and dissociation constants of proposed mu and kappa receptor agonists (morphine and ethylketocyclazocine, respectively) were compared using the method of partial irreversible blockade (with buprenorphine) and Stephenson's theory of drug action. While there was good agreement between the dissociation constant (KA) of morphine in analgesia (3.3 x 10(-5) M) and in inhibition of gastrointestinal transit (1.1 x 10(-5) M), the KA of ethylketocyclazocine differed by an order of magnitude in these endpoints (3.2 x 10(-6) M and 6.7 x 10(-5) M, respectively). The efficacies of morphine were found to be similar for the two effects studied (4.23 and 5.26), while those for ethylketocyclazocine differed markedly (2.06 and 10.39). The fraction of receptors remaining unblocked after buprenorphine was consistent for the test but not for the agonist, indicating a different distribution of receptors for the two endpoints. Our results strongly suggest that morphine induces analgesia, and slows transit in the small intestine, through the same type of receptor. The same conclusion cannot be drawn for ethylketocyclazocine. 相似文献